Starpharma
Sustainability Report and Carbon Intensity Rankings
Is Starpharma doing their part?
Their DitchCarbon score is 35
Starpharma has a DitchCarbon Score of 35 out of 100, indicating room for improvement in its sustainability practices. This score reflects a moderate level of carbon intensity in the company’s operations. To enhance its sustainability efforts, Starpharma needs to focus on reducing its carbon footprint and emissions.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Starpharma is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Starpharma, located in Australia, operates in a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may be negatively impacted by the country’s overall high carbon emissions.
Unlock 30+ emissions data points on Starpharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Starpharma
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
6.29%
...this company is doing 6.29% worse in emissions than the industry average.
Starpharma Holdings Limited, founded in 1996 and headquartered in Melbourne, operates within the industrial manufacturing sector, specifically focusing on the development of dendrimer products. As a leader in its field and part of the ASX 300, the company specializes in pharmaceutical, life science, and agrochemical applications. Starpharma offers a range of products and technologies, including the VivaGel® portfolio and DEP™ drug delivery systems, advancing its innovations through both internal development and commercial partnerships.
Bad news, Starpharma hasn't committed to SBTi goals yet
Starpharma has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.